Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 1;30(1):8-11.
doi: 10.1097/RHU.0000000000002031. Epub 2023 Sep 23.

Racial Disparities in Diagnosis and Treatment of Patients With Dermatomyositis of Different Skin Tones

Hillary Weisleder  1 , Ana Valle  2 , Xianhong Xie  3 , Shereen Mahmood  4
Affiliations

Racial Disparities in Diagnosis and Treatment of Patients With Dermatomyositis of Different Skin Tones

Hillary Weisleder et al. J Clin Rheumatol. .

Abstract

Background: Delays in the diagnosis and treatment of dermatological conditions in minorities are a well-documented health disparity. We aimed to determine if there was a delay in detection and treatment initiation for dermatomyositis (DM) and amyopathic dermatomyositis (ADM) in patients of different skin tones.

Methods: Patients from Montefiore Medical Center who met the criteria for DM and ADM were included in this cohort study. Records were reviewed for date of first documented rash, creatine kinase levels, muscle weakness complaints, and date of first steroid or disease-modifying antirheumatic drug initiation. The median number of days between rash documentation and therapy initiation was compared for patients of different races, including non-Hispanic White, non-Hispanic Black, Hispanic, and other (Asian and unknown). Data were compared in White versus non-White skin.

Results: Sixty-three DM and 9 ADM patients met the inclusion criteria. There was a shorter time to treatment initiation in White versus non-White patients, with a median number of 8 days compared with 21 days, respectively ( p = 0.05). Kaplan-Meier curves showed prolonged time to diagnosis and treatment in all other races when compared with White patients ( p = 0.03).

Discussion: It took clinicians longer to diagnose and treat DM and ADM in patients of color. The trends observed emphasize the importance of increasing dermatology education of non-White skin to improve detection and treatment of DM and ADM and minimize health disparities.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Buster KJ, Stevens EI, Elmets CA. Dermatologic health disparities. Dermatol Clin . 2012;30:53–59, viii. doi:10.1016/j.det.2011.08.002. - DOI
    1. El-Kashlan N, Alexis A. Disparities in dermatology: a reflection. J Clin Aesthet Dermatol . 2022;15:27–29.
    1. Mainetti C, Terziroli Beretta-Piccoli B, Selmi C. Cutaneous manifestations of dermatomyositis: a comprehensive review. Clinic Rev Allerg Immunol . 2017;53:337–356. doi:https://doi.org/10.1007/s12016-017-8652-1. - DOI
    1. Qudsiya Z, Waseem M. Dermatomyositis. In: StatPearls [Internet] . Treasure Island, FL: StatPearls Publishing; 2022. p. . Updated June 12, 2022. Available at: https://www.ncbi.nlm.nih.gov/books/NBK558917 . Accessed August 7, 2023
    1. Zickuhr L, Mandell BF. Rheumatology education needs a splash of color. J Rheumatol . 2022;49:343–345. doi:10.3899/jrheum.211233. - DOI